PCI looks to Boston for growth; 3M signs on to help Mylan make generic Advair;

> Contract drugmaker PCI Synthesis is increasingly looking to its native Boston for partnership deals, tapping the area's fast-growing biotech ecosystem to flesh out its client base. Story

> 3M ($MMM) has signed on to help Mylan ($MYL) manufacture the delivery device key to its generic version of GlaxoSmithKline's ($GSK) blockbuster COPD treatment Advair. News

Suggested Articles

Bayer CEO Werner Baumann stressed “less and less trust in society" for technology advances as a hurdle for pharma companies working on gene editing.

As GlaxoSmithKline looks to start a 23andMe-partnered test this year, the Big Pharma is increasingly looking to tech for its R&D.

LabCorp has unveiled a new suite of cell and gene therapy development offerings from Covance as it looks to get into this burgeoning area.